Hims & Hers Health（HIMS）今日盘中大跌13.05%，引发市场关注。这一跌幅延续了该股近日的下跌趋势，两天累计下跌已达15%，抹去了之前的涨幅。
消息面上，Hims & Hers Health近期宣布为处于围绝经期和更年期的人群推出价格亲民的治疗方案。这项新的更年期护理服务将公司的业务范围拓展至激素替代疗法领域。公司表示，预计这一新专项服务将助力其"Hers"部门在明年实现年营收超10亿美元的目标。
然而，尽管公司推出了新的业务线并设定了积极的收入目标，但投资者似乎对此反应冷淡。股价的大幅下跌可能反映了市场对公司新业务潜力的怀疑，或者是对整体估值的重新评估。此外，可能还有其他未披露的因素影响了投资者情绪，导致了这次显著的股价调整。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.